Marijke Stigter van Walsum (Afsar Rahbar, Marijke Stigter-van Walsum)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Topics

Squamous Cell Carcinoma

Gene Expression

Highly Efficient

Top Venues

EJNMMI research

The Journal of biological chemistry

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Reinout H de Roest, Marijke Stigter van Walsum, Karlijn van der Schilden, Ruud H Brakenhoff
Pharmacodynamics and biodistribution of [195mPt]cisplatin(CISSPECT®) in head and neck squamous cell carcinoma. EJNMMI research 14 (1) (2024)
Leon J Wils, Marijke Buijze, Marijke Stigter van Walsum, Arjen Brink, Britt E van Kempen, Laura A N Peferoen, Elisabeth R Brouns, Jan G A M de Visscher, Erik H van der Meij, Elisabeth Bloemena, Jos B Poell, Ruud H Brakenhoff
Genomic Engineering of Oral Keratinocytes to Establish In Vitro Oral Potentially Malignant Disease Models as a Platform for Treatment Investigation. Cells 13 (8) (2024)
Leon J Wils, Marijke Buijze, Marijke Stigter van Walsum, Arjen Brink, Britt E van Kempen, Laura A N Peferoen, Elisabeth R Brouns, Jan G A M de Visscher, Erik H van der Meij, Elisabeth Bloemena, Jos B Poell, Ruud H Brakenhoff
Genomic Engineering of Oral Keratinocytes to Establish In Vitro Oral Potentially Malignant Disease Models as a Platform for Treatment Investigation. Cells 13 (8) (2024)
Reinout H de Roest, Marijke Stigter van Walsum, Karlijn van der Schilden, Ruud H Brakenhoff
Pharmacodynamics and biodistribution of [195mPt]cisplatin(CISSPECT®) in head and neck squamous cell carcinoma. EJNMMI research 14 (1) (2024)
Leon J Wils, Marijke Buijze, Marijke Stigter van Walsum, Arjen Brink, Britt E van Kempen, Laura A N Peferoen, Elisabeth R Brouns, Jan G A M de Visscher, Erik H van der Meij, Elisabeth Bloemena, Jos B Poell, Ruud H Brakenhoff
Genomic Engineering of Oral Keratinocytes to Establish In Vitro Oral Potentially Malignant Disease Models as a Platform for Treatment Investigation. Cells 13 (8) (2024)
Reinout H de Roest, Marijke Stigter van Walsum, Karlijn van der Schilden, Ruud H Brakenhoff
Pharmacodynamics and biodistribution of [195mPt]cisplatin(CISSPECT®) in head and neck squamous cell carcinoma. EJNMMI research 14 (1) (2024)
Jantine E Bakema, Marijke Stigter van Walsum, Jeffrey R Harris, Sonja H Ganzevles, Anantharaman Muthuswamy, Mischa Houtkamp, Theo S Plantinga, Elisabeth Bloemena, Ruud H Brakenhoff, Esther C W Breij, Rieneke van de Ven
An antibody-drug conjugate directed to tissue factor shows preclinical anti-tumor activity in head and neck cancer as a single agent and in combination with chemoradiotherapy. Molecular cancer therapeutics (2023)
Mandy Gruijs, Sonja H Ganzevles, Marijke Stigter van Walsum, Richard van der Mast, Monique M van Ostaijen-Ten Dam, Cornelis W Tuk, Marco W Schilham, C René Leemans, Ruud H Brakenhoff, Marjolein van Egmond, Rieneke van de Ven, Jantine E Bakema
NK Cell-Dependent Antibody-Mediated Immunotherapy Is Improved In Vitro and In Vivo When Combined with Agonists for Toll-like Receptor 2 in Head and Neck Cancer Models. International journal of molecular sciences 22 (20) (2021)
Jeffrey R van Senten, Maarten P Bebelman, Tian Shu Fan, Raimond Heukers, Nick D Bergkamp, Puck van Gasselt, Ellen V Langemeijer, Erik Slinger, Tonny Lagerweij, Marijke Stigter van Walsum, Marijke Stigter-van Walsum, David Maussang, Rob Leurs, René J P Musters, Guus A M S van Dongen, Cecilia Söderberg-Nauclér, Thomas Würdinger, Marco Siderius, Martine J Smit
The human cytomegalovirus-encoded G protein-coupled receptor UL33 exhibits oncomodulatory properties. The Journal of biological chemistry 294 (44) (2019)